CTx1000 designed to clear pathological TDP-43 protein, a central driver of ALS . SYDNEY, March 24, 2026 /PRNewswire/ -- Celosia Therapeutics, an Australian biotech company develop ...
During intensive care after preterm births, babies can experience low oxygen in their tissue and cells-or hypoxia.
A new research project aims to develop the world’s first therapy to eliminate and prevent the spread of a toxic brain protein that drives Parkinson’s disease. Innovation Fund Denmark has invested DKK ...
New treatments for neurodegenerative diseases like Alzheimer's, Parkinson's, and motor neuron disease (MND) could be unlocked ...
Fitgurú on MSN
Could this simple food be the secret to a healthier brain? Experts say it may protect memory
Protecting brain health may be simpler than many people think. According to neurologists and nutrition experts, one everyday ...
Q4 2025 Earnings Call March 18, 2026 4:30 PM EDTCompany ParticipantsMaria Sainz - CEO, President & DirectorBrett Hale - ...
Q4 2025 earnings call recap: revenue surge after Greenbrook, 2026 guidance, CEO transition, cash flow and key risks.
Total revenue of $41.8 million in Q4 2025, up 86% as reported and 23% on an adjusted pro forma basis versus Q4 2024 Greenbrook clinic revenue of $23.5 million in Q4 2025, up 428% as reported and 37% ...
Charging Speed & Battery Lifespan: Scalvy's architecture embeds module-level control, enabling dynamic state-of-charge (SoC) ...
A tech whizz with Motor Neurone Disease (MND) has turned his home into a Wallace & Gromit-style lab of inventions to help him ...
Mutation found in high-altitude animals may help repair myelin damage and support new treatments for neurological disorders ...
Specific neurons in the motor cortex of the brain are linked to Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results